CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+3.15%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$3.85B
AUM Growth
-$153M
(-3.8%)
Cap. Flow
-$305M
Cap. Flow
% of AUM
-7.93%
Top 10 Holdings %
Top 10 Hldgs %
17.74%
Holding
706
New
68
Increased
289
Reduced
229
Closed
52
Top Buys
| 1 |
AET
Aetna Inc
AET
|
$22.9M |
| 2 |
Abbott
ABT
|
$22.2M |
| 3 |
Johnson & Johnson
JNJ
|
$21.7M |
| 4 |
Analog Devices
ADI
|
$19.2M |
| 5 |
Cummins
CMI
|
$17.1M |
Top Sells
| 1 |
Intel
INTC
|
$46M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$38.4M |
| 3 |
AbbVie
ABBV
|
$37.7M |
| 4 |
NVIDIA
NVDA
|
$24.7M |
| 5 |
Gilead Sciences
GILD
|
$22.7M |
Sector Composition
| 1 | Healthcare | 24.55% |
| 2 | Financials | 13.06% |
| 3 | Technology | 10.26% |
| 4 | Consumer Staples | 10.19% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KDNY
501
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $654K | 0.02% |
11,567
| – | – |
|
502
RenaissanceRe
RNR
$11.4B
| $651K | 0.02% |
5,539
+440
| +9% | +$51.7K |
|
503
Larimar Therapeutics
LRMR
$342M
| $647K | 0.02% |
9,000
| – | – |
|
|
BCR
504
DELISTED
CR Bard Inc.
BCR
| $646K | 0.02% |
2,745
+244
| +10% | +$57.4K |
|
505
Hasbro
HAS
$11.2B
| $645K | 0.02% |
7,685
| – | – |
|
|
CLVS
506
DELISTED
Clovis Oncology, Inc.
CLVS
| $645K | 0.02% |
47,000
+15,000
| +47% | +$206K |
|
507
IQVIA
IQV
$31.8B
| $640K | 0.02% |
9,790
+1,916
| +24% | +$125K |
|
508
PTC
PTC
$25.3B
| $639K | 0.02% |
17,000
+4,300
| +34% | +$162K |
|
509
AXIS Capital
AXS
$7.64B
| $638K | 0.02% |
11,602
+692
| +6% | +$38.1K |
|
510
Labcorp
LH
$23B
| $638K | 0.02% |
5,699
-20,228
| -78% | -$2.26M |
|
|
DISH
511
DELISTED
DISH Network Corp.
DISH
| $633K | 0.02% |
12,086
-5,082
| -30% | -$266K |
|
512
Everest Group
EG
$14.3B
| $632K | 0.02% |
3,460
+30
| +0.9% | +$5.48K |
|
513
Campbell Soup
CPB
$10B
| $631K | 0.02% |
+9,486
| New | +$631K |
|
|
TCON
514
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $626K | 0.02% |
715
-100
| -12% | -$87.6K |
|
515
Markel Group
MKL
$24.2B
| $619K | 0.02% |
+650
| New | +$619K |
|
516
Ambarella
AMBA
$3.51B
| $610K | 0.02% |
12,000
| – | – |
|
517
Federal Realty Investment Trust
FRT
$8.82B
| $598K | 0.02% |
3,610
-3,119
| -46% | -$517K |
|
518
Essex Property Trust
ESS
$17.2B
| $597K | 0.02% |
+2,619
| New | +$597K |
|
519
Church & Dwight Co
CHD
$23.2B
| $591K | 0.02% |
11,490
| – | – |
|
|
CAJ
520
DELISTED
Canon, Inc.
CAJ
| $584K | 0.02% |
20,400
| – | – |
|
|
GBT
521
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $581K | 0.02% |
+35,000
| New | +$581K |
|
522
Imperial Oil
IMO
$44.4B
| $565K | 0.01% |
17,945
+3,507
| +24% | +$110K |
|
|
PBCT
523
DELISTED
People's United Financial Inc
PBCT
| $558K | 0.01% |
+38,028
| New | +$558K |
|
|
CA
524
DELISTED
CA, Inc.
CA
| $558K | 0.01% |
16,994
+1,801
| +12% | +$59.1K |
|
|
PRTK
525
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $556K | 0.01% |
+40,000
| New | +$556K |
|